Milken Institute
Showing 361–375 of 2093 transcripts.
- 31 min
A Conversation with Arthur Brooks on Global Prosperity | Middle East and Africa Summit 2024
Arthur Brooks, Shikha Jain, Conrad Kiechel
At the 6th Annual Milken Institute Middle East and Africa Summit, Harvard professor Arthur Brooks defined happiness as a science-driven pursuit anchored by faith, family, friendship, and merit-based work rather than the accumulation of wealth or status. Brooks detailed how strategic philanthropy, limited social media usage, and deep existential reflection serve as critical mechanisms for sustaining mental well-being and strengthening marital bonds. His presentation concluded with a call for global leaders to adopt personal mission statements that prioritize serving others, effectively transforming professional success into a vehicle for collective human fulfillment.
- 26 min
Game On: Unlocking the Social Impact of Sports | Middle East and Africa Summit 2024
Melissa Stevens, Christian Horner, Wladimir Klitschko
At a Milken Institute panel moderated by Melissa Stevens, Christian Horner of Oracle Red Bull Racing and Dr. Vladimir Klitschko of the Klitschko Foundation discussed leveraging sports to drive social change through STEM education, diversity initiatives, and trauma-informed youth programs. Horner detailed how Formula One utilizes massive data collaboration and inclusive team cultures to foster engineering talent, while Klitschko outlined his "Face the Challenge" methodology and the strategic pivot of his foundation to support Ukraine following the 2022 invasion. Both leaders concluded that intentional partnerships are essential for sports to effectively dismantle societal barriers and act as a unified force for global evolution.
- 20 min
A Conversation with First Lady of the United States Jill Biden | Middle East and Africa Summit 2024
Launched in November 2023, President Biden and Dr. Jill Biden initiated the Women's Health Initiative to rectify century-old biases in clinical research by allocating over $1 billion across the NIH, DOD, and ARPA-H for targeted studies on heart disease, endometriosis, and menopause. This federal mobilization aims to eliminate diagnostic delays and economic losses exceeding $2 billion annually, with projections suggesting the initiative could unlock $1 trillion in global economic value by 2040 by reintegration millions of women into the workforce. The program addresses a critical global demand for evidence-based data while challenging misinformation to ensure women experience decades of healthy living rather than the current decade of poor health.
- 33 min
Art of Storytelling: Shaping Culture, Identity, & Global Impact | Middle East and Africa Summit 2024
Louise Tabbiner, Edward Norton, Elie Saab Jr.
Moderated by Milken Institute Senior Advisor Louise Tabiner, Edward Norton and Elie Saab Jr. examined how authentic storytelling drives business strategy, cultural identity, and global impact. Norton emphasized the power of narrative to address ecological challenges and foster personal balance, while Saab Jr. detailed the family-owned brand's non-negotiable focus on transparency and organic expansion into new verticals. The panelists concluded that successful persuasion requires refining narratives through personal experience and leveraging shared human experiences, such as sports and heritage, to bridge cultural divides.
- 1h 14m
Navigating a Changing Global Economy | Middle East and Africa Summit 2024
Laura Deal Lacey, Michael Milken, His Royal Highness Prince Turki Al Faisal Al Saud, Makhtar Diop, Mohamed Mansour, Alan Schwartz, Prince Turki Al Faisal Al Saud
Held in Abu Dhabi in December 2024, the 6th Annual Middle East and Africa Summit convened global leaders from the Milken Institute, the International Finance Corporation, and the Mansour Group to mobilize capital toward healthcare, economic development, and environmental sustainability. The event highlighted a strategic pivot where emerging markets are transforming from passive capital providers into technology hubs capable of bridging the gap between the aging Global North and Africa's young, growing workforce. Participants addressed critical investment barriers such as regulatory uncertainty and currency mismatches by proposing blended finance models and de-risking strategies to unlock trillions of dollars in private and philanthropic resources.
- 20 min
A Conversation with CMS Director of Medicare Meena Seshamani | Future of Health Summit 2024
Meena Seshamani, Bertha Coombs
A multidisciplinary team comprising experts from drug pricing, pharmacy, and economics has implemented health care reforms focused on treating developmental issues, chronic illnesses, and behavioral health within the Medicare and Medicaid systems. These initiatives, which include updating risk adjustment methodologies and navigating the Inflation Reduction Act, aim to reduce prescription drug costs for seniors and integrate services to address over 400,000 additional conditions. With a target deadline of September 1st for international financial agreements, the organization plans to execute these changes over five to eight months while utilizing new communication platforms and patient feedback to ensure system stability.
- 1h 1m
Decoding Disease: Can Genetics Unlock New Interventions? | Future of Health Summit 2024
Conor Hale, Colleen Campbell, Lon Cardon, Bernard Kwabi-Addo, Benjamin Neale
Experts highlight that while genomic knowledge has expanded to 12,000 identified variants, translating these discoveries into clinical care remains hindered by insurance barriers, provider literacy gaps, and biased data representation. To overcome these bottlenecks, the field is increasingly leveraging artificial intelligence for tumor heterogeneity analysis and shifting toward deconstructing common diseases into rare, monogenic subsets for targeted therapies. With sequencing costs dropping to roughly $200, stakeholders anticipate widespread population screening programs and systematic variant analysis across human diseases becoming feasible within the next decade.
- 53 min
Health Care of the Future | Future of Health Summit 2024
Michael Milken, Alex Azar, Buddy Carter, Diana DeGette, Renee Wegrzyn
The event detailed how ARPA-H and legislative initiatives like "Cures 2.0" are addressing systemic healthcare challenges by funding high-risk biomedical innovations and ensuring pharmaceutical independence. Key figures including Rep. Diana DeGette and Rep. Chris Carter highlighted strategies to reform Medicare Advantage payment models and repatriate drug manufacturing to counter supply chain vulnerabilities. The panel concluded with a call for increased federal investment in translational science and a broader call for business leaders to enter government to sustain the pace of medical breakthroughs.
- 20 min
A Conversation with FDA Commissioner Robert Califf | Future of Health Summit 2024
Commissioner Califf reflects on his tenure managing the Abbott infant formula recall and reorganizing the FDA Food Program, emphasizing that the agency faces a healthcare delivery crisis rather than an innovation deficit despite the U.S. global leadership in scientific advancement. He advocates for shifting regulatory focus from pre-approval trials to post-market pragmatic studies and new frameworks for AI decision support to address systemic biases and monitor uncontrolled algorithmic drift in clinical environments. Califf concludes by defining essential traits for future leadership, prioritizing executive listening skills and a commitment to high-quality evidence generation while maintaining a strict separation between science-based product decisions and politically influenced policy mandates.
- 43 min
Partnerships Leading to a Healthier Tomorrow | Future of Health Summit 2024
Meg Tirrell, Yele Aluko, John Crowley, Kody Kinsley, Pablo Legorreta
Moderated by a panel including BIO President John Crowley and North Carolina HHS Secretary Cody Kinsley, industry leaders and officials discussed strategies to overcome systemic inefficiencies and reduce the $500 billion in annual waste within the US healthcare sector. Speakers highlighted North Carolina's successful Medicaid expansion and debt relief initiatives as a model for addressing social determinants of health, while advocating for regulatory reforms and non-dilutive financing to accelerate biotechnology innovation. The dialogue concluded with a unified call to shift the industry focus from reactive volume-based care to preventive measures and equitable access, emphasizing the role of technology in creating a more sustainable and efficient national health system.
- 1h 11m
Global Collaboration to Eradicate Women’s Cancers | Future of Health Summit 2024
Alice Park, Usman Malami Aliyu, Danielle Carnival, Dave Fredrickson, Roberta Lipson, Gemma Peters
Global cancer leaders convened to address the projected doubling of incidence in low- and middle-income countries by implementing diverse strategies ranging from Nigeria's mobile screening vans and mobile PCR labs in China to the UK's data-driven risk assessment partnerships. These initiatives prioritize overcoming structural inequities in treatment access, financial barriers, and clinical trial participation through innovations like AI-driven imaging, drug repurposing, and targeted care navigation programs. Ultimately, the consensus emphasizes that sustainable national cancer control plans must integrate geopolitical cooperation and equity-first designs to prevent the fragmentation of global research and ensure effective prevention for the most vulnerable populations.
- 58 min
Innovation for All: Strategies for Maximizing Impact | Future of Health Summit 2024
Matthew Herper, Jay Bradner, Debi Brooks, Lisa D. Earnhardt, Elizabeth Fowler, Marc Samuels
This event synthesized breakthroughs in Parkinson's biomarker detection, the genetic discovery of obesity-protective alleles, and strategies to expand medical device access for underserved populations. Industry leaders and regulators discussed how these scientific advances confront systemic barriers in delivery and reimbursement, particularly regarding the high costs of gene therapies and the misalignment of current billing models with preventative care. The consensus emphasized that future progress depends on shifting focus from pure biological innovation to collaborative frameworks that ensure scalable manufacturing, equitable access, and payment reforms based on patient outcomes.
- 1h 0m
Why Younger People Are Getting Cancer and What We Can Do About It | Future of Health Summit 2024
Dylan Scott, Karen Knudsen, Harlan Levine, Mohit Manrao, Kimryn Rathmell, AmirAli Talasaz
A comprehensive 24-million-person study spanning two decades reveals that 17 of 34 major cancer types are rising significantly among Millennials and Gen X, prompting the American Cancer Society to lower screening thresholds despite critical barriers in adoption and access. To address this "tsunami" of young survivors facing unique fertility, financial, and care challenges, the field is transitioning toward liquid biopsy innovations and multidisciplinary "living" guideline frameworks to bridge the gap between community providers and academic centers. While precision medicine and expanded immunotherapy trials offer hope for improved survival, the crisis persists due to outdated insurance models, systemic disparities, and a significant lag between emerging scientific evidence and updated clinical protocols.
- 54 min
Connecting the Dots for Women's Health: Innovation, Access, & Care | Future of Health Summit 2024
Ruth Reader, Sandra Brooks, Trish Costello, Jenica Patterson, Ana Maria Ramirez, Tammy Sun
As of last week, ARPA-H has obligated $113 million in federal funding to support women's health research through Spark and Launchpad awards targeting conditions like Alzheimer's, endometriosis, and maternal mortality. This investment coincides with a 300% surge in venture capital for the sector since 2018, driving innovations in male contraception and non-pharmacological treatments despite persistent racial disparities and access barriers. While bipartisan funding provides short-term stability, experts warn that evolving legal landscapes regarding abortion and the politicization of data privacy pose significant risks to future reproductive health outcomes.
- 40 min
Bot or Not?: AI in Health Care | Future of Health Summit 2024
Richard Lui, Dipanwita Das, John Halamka, Vidya Raman-Tangella
Industry leaders including Sociero CEO Dipanita Das, Mayo Clinic President Dr. John Halamka, and Teladoc CMO Vidya Rahman convened to argue that while technical barriers to healthcare AI have dissolved, cultural resistance and data heterogeneity now impede transformative progress. The panel highlighted critical successes such as Mayo Clinic's ability to detect Stage Zero pancreatic cancer and Teladoc's use of generative AI for personalized patient engagement, underscoring the necessity of embedding real-world evidence and clinical validation into care pathways. Ultimately, the group urged a strategic shift from adopting technology for novelty to solving specific operational problems, calling for a global federated data network to achieve a preventative "precision health" vision for four billion people by 2030.